Related Experiment Video
Updated: May 25, 2026

Screening Ion Channels in Cancer Cells
Published on: June 16, 2023
Targeting ion channels for the treatment of gastrointestinal motility disorders
Arthur Beyder1, Gianrico Farrugia
1Enteric Neuroscience Program, Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Insights
Gastrointestinal motility disorders affect many people, but treatments are challenging. This review explores voltage-sensitive ion channels (VSICs) in smooth muscle cells and interstitial cells of Cajal as potential therapeutic targets.
Area of Science:
- Gastroenterology
- Molecular Biology
- Physiology
Background:
- Gastrointestinal (GI) functional and motility disorders are common, causing significant morbidity.
- Diagnosis and treatment are challenging due to complex pathophysiology involving nervous systems and GI wall.
- Interstitial cells of Cajal (ICCs) and smooth muscle cells (SMCs) generate electrical activity via voltage-sensitive ion channels (VSICs).
Purpose of the Study:
- To review the role of VSICs in GI motility.
- To discuss the molecular mechanisms of VSICs in ICCs and SMCs.
- To explore targeting VSICs for therapeutic interventions in GI motility disorders.
Main Methods:
- Review of literature on VSICs in GI physiology.
- Analysis of molecular and structural biology data.
- Electrophysiological studies of ICCs and SMCs.
Main Results:
- VSICs, including Na(V), Ca(V), K(V), K(Ca), Cl(-), and TRP channels, are crucial for GI electrical activity.
- These channels exhibit structural homology and common functional mechanisms.
- Targeting specific sites on VSICs offers potential for drug development.
Conclusions:
- VSICs are key regulators of GI electrical activity and motility.
- Understanding VSIC structure and function is vital for developing new therapies.
- Targeting VSICs presents a promising strategy for managing GI motility disorders.
Abstract:
Gastrointestinal (GI) functional and motility disorders are highly prevalent and responsible for long-term morbidity and sometimes mortality in the affected patients. It is estimated that one in three persons has a GI functional or motility disorder. However, diagnosis and treatment of these widespread conditions remains challenging. This partly stems from the multisystem pathophysiology, including processing abnormalities in the central and peripheral (enteric) nervous systems and motor dysfunction in the GI wall. Interstitial cells of Cajal (ICCs) are central to the generation and propagation of the cyclical electrical activity and smooth muscle cells (SMCs) are responsible for electromechanical coupling. In these and other excitable cells voltage-sensitive ion channels (VSICs) are the main molecular units that generate and regulate electrical activity. Thus, VSICs are potential targets for intervention in GI motility disorders. Research in this area has flourished with advances in the experimental methods in molecular and structural biology and electrophysiology. However, our understanding of the molecular mechanisms responsible for the complex and variable electrical behavior of ICCs and SMCs remains incomplete. In this review, we focus on the slow waves and action potentials in ICCs and SMCs. We describe the constituent VSICs, which include voltage-gated sodium (Na(V)), calcium (Ca(V)), potassium (K(V), K(Ca)), chloride (Cl(-)) and nonselective ion channels (transient receptor potentials [TRPs]). VSICs have significant structural homology and common functional mechanisms. We outline the approaches and limitations and provide examples of targeting VSICs at the pores, voltage sensors and alternatively spliced sites. Rational drug design can come from an integrated view of the structure and mechanisms of gating and activation by voltage or mechanical stress.
Related Concept Videos
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Gastrointestinal Motility Disorders
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Drugs for Treatment of Constipation-Predominant IBS

